Blood tests could reveal hidden brain tumor activity
NCT ID NCT07417774
First seen Feb 25, 2026 · Last updated May 09, 2026 · Updated 10 times
Summary
This study is for 40 people with glioblastoma, a serious brain cancer, who are already in a larger trial testing an oxygen-boosting drug. Researchers will take blood samples (liquid biopsies) to look for markers that show how the tumor responds to treatment. The goal is to better tell apart tumor growth from treatment side effects and find clues about the tumor's oxygen levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Neurosciences
Tucson, Arizona, 85718, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Saint Luke's Cancer Institute
Kansas City, Missouri, 64111, United States
-
Yale Cancer Center
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.